443 related articles for article (PubMed ID: 34831119)
1. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.
Oda Y; Walter H; Radig K; Röse I; Neumann W; Roessner A
J Cancer Res Clin Oncol; 1995; 121(11):667-73. PubMed ID: 7593131
[TBL] [Abstract][Full Text] [Related]
3. Expression of bone morphogenetic proteins and receptors in sarcomas.
Guo W; Gorlick R; Ladanyi M; Meyers PA; Huvos AG; Bertino JR; Healey JH
Clin Orthop Relat Res; 1999 Aug; (365):175-83. PubMed ID: 10627702
[TBL] [Abstract][Full Text] [Related]
4. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
[TBL] [Abstract][Full Text] [Related]
6. Experimental therapies and clinical trials in bone sarcoma.
Chugh R
J Natl Compr Canc Netw; 2010 Jun; 8(6):715-25. PubMed ID: 20581301
[TBL] [Abstract][Full Text] [Related]
7. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Devaney K; Vinh TN; Sweet DE
Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
[TBL] [Abstract][Full Text] [Related]
8. Pelvic bone sarcomas: controversies and treatment options.
Morris CD
J Natl Compr Canc Netw; 2010 Jun; 8(6):731-7. PubMed ID: 20581302
[TBL] [Abstract][Full Text] [Related]
9. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of factors affecting survival rate in primary bone sarcomas with extremity and pelvis involvement.
Sofulu Ö; Erol B
Acta Orthop Traumatol Turc; 2020 May; 54(3):234-244. PubMed ID: 32544060
[TBL] [Abstract][Full Text] [Related]
11. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
[TBL] [Abstract][Full Text] [Related]
12. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
13. Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody.
Yoshikawa H; Rettig WJ; Takaoka K; Alderman E; Rup B; Rosen V; Wozney JM; Lane JM; Huvos AG; Garin-Chesa P
Cancer; 1994 Jan; 73(1):85-91. PubMed ID: 7506120
[TBL] [Abstract][Full Text] [Related]
14. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
15. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
Merchant MS; Woo CW; Mackall CL; Thiele CJ
J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
[TBL] [Abstract][Full Text] [Related]
16. EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1.
Sáinz-Jaspeado M; Huertas-Martinez J; Lagares-Tena L; Martin Liberal J; Mateo-Lozano S; de Alava E; de Torres C; Mora J; Del Muro XG; Tirado OM
PLoS One; 2013; 8(8):e71449. PubMed ID: 23951165
[TBL] [Abstract][Full Text] [Related]
17. Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.
Dai X; Ma W; He X; Jha RK
Med Sci Monit; 2011 Aug; 17(8):RA177-190. PubMed ID: 21804475
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.
Damron TA; Ward WG; Stewart A
Clin Orthop Relat Res; 2007 Jun; 459():40-7. PubMed ID: 17414166
[TBL] [Abstract][Full Text] [Related]
19. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors.
Kushlinskii NE; Alferov AA; Timofeev YS; Gershtein ES; Bulycheva IV; Bondarev AV; Shchupak MY; Sokolov NY; Polikarpova SB; Efimova MM; Dzampaev AA; Sushentsov EA; Aliev MD; Musaev ER
Bull Exp Biol Med; 2020 Nov; 170(1):64-68. PubMed ID: 33231796
[TBL] [Abstract][Full Text] [Related]
20. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
[No Abstract] [Full Text] [Related]
[Next] [New Search]